Skip to main content

Exome Asset Management LLC

SEC CIK
0002011932
Latest filing
Aug 14, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Exome Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2026)
22,417
Value
$1.56M
% of portfolio
1.0%
Quarters held
3
Since Q4 2024
Holdings of NKTR by Exome Asset Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,417$1.56M1.0%+22,417NewHolders
Q2 20250$00.0%−148,830−100.0%Sold outConverted for a 1-for-15 splitHolders
Q1 20252,232,453$1.52M1.4%+1,614,279+261.1%AddedHolders
Q4 2024618,174$574.9K0.4%+618,174NewHolders